Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals Earns Composite Rating Upgrade

The IBD SmartSelect Composite Rating for Kiniksa Pharmaceuticals rose from 83 to 97 Wednesday.

Investors Business Daily

Stocks Showing Improving Market Leadership: Kiniksa Pharmaceuticals Earns 87 RS Rating

A Relative Strength Rating upgrade for Kiniksa Pharmaceuticals shows improving technical performance.

Investors Business Daily

Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Is Strong Tailwind

Biotech stock Kiniksa soared after first-quarter results on April 29. Shares are near a buy point of 28.15.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

3 'Strong Buy' Small-Cap Stocks to Snag Now for a Soft Landing

Explore three small-cap stocks with 'Strong Buy' ratings that are poised for significant growth as economic conditions hint at a potential soft landing.

Barchart

5 Biotech Stocks With 26% Upside Potential or More

As biotech stocks swing back into favor on Wall Street, here's a look at five picks that could deliver significant gains, according to analysts.

Barchart

Recap: Kiniksa Pharmaceuticals Q1 Earnings

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Earnings Scheduled For May 3, 2022

Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Kiniksa Pharmaceuticals: Q4 Earnings Insights

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q4 earnings results on Tuesday, February 22, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Organisations

Investor Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.